To find out if local consolidation therapy (such as radiation therapy with or without other local therapies such as surgery, ablation \[the removal or destruct…

OligoProgressive Metastatic Disease

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT06367972

Phase 2

STING Agonist and Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer.

To evaluate the impact of combining innate immune system activation (with IMSA101) with antigen release (through SAbR/PULSAR) on limited progressing lesions du…

Metastatic Renal Cell Carcinoma ( mRCC)OligoProgressive Metastatic Disease

~Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT06601296